NCT06857357

Brief Summary

Tampa Kinesiophobia Scale is a scale that has been validated and reliable in individuals with low back pain in the Turkish population and evaluates fear of movement due to the risk of triggering pain. Especially for migraine headache, patients have complaints about movement and fear of movement, and in addition, according to the International Classification of Headache Disorders, 3rd Edition criteria, the item of aggravation with physical activity is considered as a diagnostic criterion. Migraine patients may theoretically start their attacks due to hypocretin neuropeptide and lactate metabolism dysfunction. It has been stated that calcitonin gene-related peptide (CGRP), which is released during migraine attacks, is also released during exercise and intense physical activity and can trigger attacks. Therefore, patients avoid physical activity and exercise. It has been stated that movements that do not require effort can also trigger attacks in migraine patients. The aim of this study is to investigate the validity and reliability of the Tampa Kinesiophobia Scale for Headache in patients with migraine for the Turkish population. The potential relationships between the scale and the beliefs about headache intensity, disability, headache impact, anxiety and depression will also be evaluated and whether the characteristics of the three types of headaches are similar or different from kinesiophobia will be investigated. Hypothesis: H0: The Tampa Kinesiophobia Scale for Headache is not valid and reliable for the Turkish population in patients with migraine H1: The Tampa Kinesiophobia Scale for Headache is valid and reliable for the Turkish population in patients with migraine

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
329

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2025

Shorter than P25 for all trials

Geographic Reach
2 countries

14 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 2, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 26, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 4, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 28, 2025

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2025

Completed
Last Updated

July 8, 2025

Status Verified

July 1, 2025

Enrollment Period

5 months

First QC Date

February 26, 2025

Last Update Submit

July 4, 2025

Conditions

Keywords

Migrainekinesiophobia

Outcome Measures

Primary Outcomes (4)

  • Visual Analog Scale

    The visual analog scale consists of the pain level that the person currently experiences with a vertical line on a plane. The pain felt by the person is marked as "0: no pain at all", "10: I feel very severe pain". Scoring is based on the vertical marking the participant makes for the pain he/she marks on the plane with a ruler.

    In first enrollment, 1 minute

  • Migraine Disability Assessment Questionnaire

    Disability of migraine patients will be assessed with the Migraine Disability Assessment Questionnaire (MEDA). MEDA assesses the last 3 months of disability and consists of a 5-item self-administered test covering disability-related activities at work/school, housework, family, and social or leisure. The total number of days missed in these activities is the total score and classifies disability as minimal disability (0-5 points), mild disability (6-10 points), moderate disability (11-20 points), or severe disability (≥21).

    In first enrollment, 1 minute

  • Headache Impact Test-6

    The impact of headache will be assessed with the Headache Impact Test-6 (HIT-6). HIT-6 is a quality of life questionnaire for headaches that assesses vitality, pain, psychological distress, sociability, role, and cognitive functioning. Each item is scored on a 5-point Likert scale (6=never, 8=rarely, 10=sometimes, 11=very often, 13=always). The total score is determined by summing the scores on the six items and ranges from 36 to 78 points. (≤49 = little/no impact, 50-55 = some impact, 56-59 = significant impact, and 60-78 = severe impact; higher scores indicate greater deterioration in quality of life).

    In first enrollment, 3 minutes

  • Hospital Anxiety and Depression Scale

    Anxiety and depression will be assessed with the Hospital Anxiety and Depression Scale (HADS). 7 items of the 14-item scale assess anxiety and 7 items assess depression symptoms. It is scored between 0-3 points. By summing the subscale scores, 0-21 points can be obtained from each of the Depression and Anxiety subscales. It is stated that 0-7 points are the normal range for each subscale, 8-10 points suggest the presence of a mood disorder, and 11 and above points indicate a possible mood disorder. In addition, there are recommended cut-off scores for mild (8-10 points), moderate (11-15) and severe (16 and above) cases.

    In first enrollment, 3 minutes

Interventions

The Tampa Kinesiophobia Questionnaire is a 17-question questionnaire that assesses avoidance of injury and fear of movement. The scale is scored using a Likert scale (1 = Strongly disagree, 4 = Strongly agree). Items 4, 8, 12 and 16 are reversed to calculate the total score of the scale. The total score is between 17 and 68. As the score of the person increases, it is understood that their kinesiophobia is high. A total score higher than 37 is considered as high kinesiophobia. However, since not every item of the questionnaire addresses patients with headache in this study, some questions were removed, some questions were edited and some questions were added to create a kinesiophobia questionnaire for headache. The newly created questionnaire consists of 23 items. Again, it is scored using a Likert scale with "1 = Strongly disagree, 4 = Strongly agree". As the score increases, it is understood that the level of kinesiophobia is high.

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients between the ages of 18-70 who applied to neurology departments of Mersin University, Gazi University, Zonguldak Bülent Ecevit University, Kütahya Health Sciences University, Gaziantep City Hospital, Silivri State Hospital, Trakya University, and Elite Research and Surgery Hospital and who were diagnosed with episodic/chronic migraine according to the International Classification of Headache Disorders, 3rd Edition, by a neurologist who is an expert in the field of headache will be included in the study.

You may qualify if:

  • Being diagnosed with episodic/chronic migraine,
  • Being between the ages of 18-70,
  • Being able to read, speak, understand and write Turkish in order to understand and correctly answer the items/questions of the surveys and scales.

You may not qualify if:

  • Having a diagnosis of episodic/chronic migraine,
  • Having a history of any systemic disease such as malignant, inflammatory, acute fracture, surgery, neurological, psychological, or rheumatological.
  • Not being able to read Turkish.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (14)

Elite Research and Surgical Hospital

Nicosia, Cyprus

Location

Bozok University

Yozgat, Merkez, 66100, Turkey (Türkiye)

Location

Gazi University

Ankara, Yenimahalle, 06560, Turkey (Türkiye)

Location

Mersin University

Mersin, Yenisehir, 33100, Turkey (Türkiye)

Location

Ankara Atatürk Sanatoryum Training and Research Hospital

Ankara, Turkey (Türkiye)

Location

Gazi University

Ankara, Turkey (Türkiye)

Location

Trakya University

Edirne, Turkey (Türkiye)

Location

Gaziantep City Hospital

Gaziantep, Turkey (Türkiye)

Location

İstanbul University

Istanbul, Turkey (Türkiye)

Location

Silivri State Hospital

Istanbul, Turkey (Türkiye)

Location

Kütahya Health Sciences University

Kütahya, Turkey (Türkiye)

Location

Headache and Cognition Clinic of Aynur Ozge

Mersin, Turkey (Türkiye)

Location

Tokay Gaziosmanpaşa University

Tokat Province, Turkey (Türkiye)

Location

Zonguldak Bülent Ecevit University

Zonguldak, Turkey (Türkiye)

Location

Related Publications (16)

  • Schmidt S, Bullinger M. Current issues in cross-cultural quality of life instrument development. Arch Phys Med Rehabil. 2003 Apr;84(4 Suppl 2):S29-34. doi: 10.1053/apmr.2003.50244.

    PMID: 12692769BACKGROUND
  • Scirepreject. The Hospital Anxiety and Depression Scale (HADS) http://www.scireproject.com/book/export/html/78.

    BACKGROUND
  • Snaith RP. The Hospital Anxiety And Depression Scale. Health Qual Life Outcomes. 2003 Aug 1;1:29. doi: 10.1186/1477-7525-1-29.

    PMID: 12914662BACKGROUND
  • Aydemir Ö, Güvenir T, Küey L, Kültür S. Hastane Anksiyete ve Depresyon Ölçeğinin Türkçe formunun geçerlik ve güvenilirlik çalışması. Türk Psikiyatri Dergisi 1997;8(4):280-287

    BACKGROUND
  • Dikmen PY, Bozdag M, Gunes M, Kosak S, Tasdelen B, Uluduz D, Ozge A. Reliability and Validity of Turkish Version of Headache Impact Test (HIT-6) in Patients with Migraine. Noro Psikiyatr Ars. 2020 Apr 24;58(4):300-307. doi: 10.29399/npa.24956. eCollection 2021.

    PMID: 34924791BACKGROUND
  • Kilinc HE, Oz M, Berberoglu U, Ozel Asliyuce Y, Onan D, Fanuscu A, Ulger O. Cross-cultural adaptation, reliability and validity of the Turkish version of the Henry Ford Hospital Headache Disability Inventory (HDI/T) in patients with cervicogenic headache. Disabil Rehabil. 2024 Feb;46(4):820-827. doi: 10.1080/09638288.2023.2178679. Epub 2023 Feb 14.

    PMID: 36788454BACKGROUND
  • Ertas M, Siva A, Dalkara T, Uzuner N, Dora B, Inan L, Idiman F, Sarica Y, Selcuki D, Sirin H, Oguzhanoglu A, Irkec C, Ozmenoglu M, Ozbenli T, Ozturk M, Saip S, Neyal M, Zarifoglu M; Turkish MIDAS group. Validity and reliability of the Turkish Migraine Disability Assessment (MIDAS) questionnaire. Headache. 2004 Sep;44(8):786-93. doi: 10.1111/j.1526-4610.2004.04146.x.

    PMID: 15330825BACKGROUND
  • Price DD, McGrath PA, Rafii A, Buckingham B. The validation of visual analogue scales as ratio scale measures for chronic and experimental pain. Pain. 1983 Sep;17(1):45-56. doi: 10.1016/0304-3959(83)90126-4.

    PMID: 6226917BACKGROUND
  • Martins IP, Gouveia RG, Parreira E. Kinesiophobia in migraine. J Pain. 2006 Jun;7(6):445-51. doi: 10.1016/j.jpain.2006.01.449.

    PMID: 16750801BACKGROUND
  • Amin FM, Aristeidou S, Baraldi C, Czapinska-Ciepiela EK, Ariadni DD, Di Lenola D, Fenech C, Kampouris K, Karagiorgis G, Braschinsky M, Linde M; European Headache Federation School of Advanced Studies (EHF-SAS). The association between migraine and physical exercise. J Headache Pain. 2018 Sep 10;19(1):83. doi: 10.1186/s10194-018-0902-y.

    PMID: 30203180BACKGROUND
  • İdiman F. Baş ağrılarında son kırk yıl. Ş. Bıçakcı, M. Öztürk, S. Üçler, N. Karlı ve A. Siva.(Editörler). Başağrısı Tanı ve Tedavi Güncel Yaklaşımlar, Türk Nöroloji Derneği Başağrısı Çalışma Grubu Uygulamaları. 2018:9-22

    BACKGROUND
  • Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018 Jan;38(1):1-211. doi: 10.1177/0333102417738202. No abstract available.

    PMID: 29368949BACKGROUND
  • Vlaeyen JWS, Kole-Snijders AMJ, Boeren RGB, van Eek H. Fear of movement/(re)injury in chronic low back pain and its relation to behavioral performance. Pain. 1995 Sep;62(3):363-372. doi: 10.1016/0304-3959(94)00279-N.

    PMID: 8657437BACKGROUND
  • Yilmaz, Ö. T., Yakut, Y., Uygur, F. ve Uluğ, N. (2011). Tampa Kinezyofobi Ölçeği'nin Türkçe versiyonu ve test-tekrar test güvenirliği. Fizyoterapi Rehabilitasyon, 22(1), 44-49

    BACKGROUND
  • Burwinkle T, Robinson JP, Turk DC. Fear of movement: factor structure of the tampa scale of kinesiophobia in patients with fibromyalgia syndrome. J Pain. 2005 Jun;6(6):384-91. doi: 10.1016/j.jpain.2005.01.355.

    PMID: 15943960BACKGROUND
  • Kori SH, Miller RP, Todd D. Kinesophobia: a new view of chronic pain behaviour. Pain Management. 1990;3:35-43

    BACKGROUND

MeSH Terms

Conditions

Migraine DisordersKinesiophobia

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Headache Disorders, PrimaryHeadache DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesPhobic DisordersAnxiety DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Target Duration
2 Weeks
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

February 26, 2025

First Posted

March 4, 2025

Study Start

January 2, 2025

Primary Completion

May 28, 2025

Study Completion

May 30, 2025

Last Updated

July 8, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations